NOTICE: Thank you for visiting our site. Your experience is important to us. We're upgrading our system to better serve you. During this time, purchases and member logins will be unavailable. Full functionality will be restored by Monday, 29 July.
Thomas Hartman, President and CEO of the International Society for Pharmaceutical Engineering, is among several key industry leaders featured in this article, discussing the advantages and challenges associated with integrating AI into drug manufacturing. The article outlines expert perspectives on the state of AI, challenges with implementation, and regulatory considerations which may influence the future of AI.
Manufacturing Dive covers news and trends impacting the manufacturing space, with topics ranging from operations and regulation to technology and more.